Canada Research Roundup: Altagas, George Weston, HLS Therapeutics

HLS Therapeutics

19/11/2019 13:43

Nov 19 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian
companies, including Altagas, George Weston and HLS Therapeutics, on Tuesday. 
    
  HIGHLIGHTS
     * Altagas Ltd  ALA.TO : BMO resumes with outperform rating and price target of $23
     * George Weston Ltd  WN.TO : RBC raises target price to C$125 from C$122
     * HLS Therapeutics Inc  HLS.TO : Canaccord Genuity initiates with buy, C$22.50 target price
  
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday. Stock
entries are in alphabetical order.
        
     * Altagas Ltd  ALA.TO : BMO resumes with outperform rating and price target of C$23
     * Automotive Properties REIT  APR_u.TO : Scotiabank raises target to C$12.50 from C$11.50
     * George Weston Ltd  WN.TO : RBC raises target price to C$125 from C$122
     * HLS Therapeutics Inc  HLS.TO : Canaccord Genuity initiates with buy, C$22.50 target price
     * True North Commercial REIT  TNT_u.TO : LB Securities raises target to C$7.50 from C$7
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))